Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Remogen Omega
- Development stage
- Unknown
- Lead developer
- TRB Chemedica
- Modality
- Prodrugs/Conditional Activator Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Classical Binding Small Molecules → Small Molecules
- Administration
- Ophthalmic
01
Overview
Remogen Omega is a preservative-free, patented microemulsion eye drop formulation designed to treat dry eye syndrome and related ocular surface disorders. It contains topical omega-3 polyunsaturated fatty acids—specifically eicosapentaenoic acid (EPA) ethyl ester and docosahexaenoic acid (DHA) ethyl ester—as well as vitamin E (α-tocopheryl acetate), glycerol, polyacrylic acid, acrylates/alkyl acrylate crosspolymer, sodium hydroxide, disodium phosphate, and water for injections[3][7]. The formulation stabilizes all three layers of the tear film by replenishing essential lipids and providing hydration. This helps reduce evaporation of the tear film and protects the corneal surface from dryness, irritation, burning sensations, redness, foreign body sensation, pain due to dry eye syndrome (including keratitis or Sjögren’s syndrome), environmental factors (dust/smoke/air conditioning), immune system diseases affecting tear secretion or medication-induced dry eyes[1][2][3]. The product is suitable for use with both rigid and soft contact lenses. Clinical studies have shown that Remogen Omega effectively alleviates symptoms of moderate to severe dry eye without significant safety concerns[5].
- Brand names
- Remogen Omega
- Other names
- REMOGEN OMEGAREMOGEN® OMEGA
Beyond the preview
Go deeper on Remogen Omega.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Remogen Omega.